Why the study?
The mechanisms underlying functional gastrointestinal disorders and effective treatment options remain unclear.
Does transcutaneous auricular vagus nerve stimulation improve symptoms in patients with functional gastrointestinal disorders?
Does transcutaneous auricular vagus nerve stimulation improve symptoms in patients with functional gastrointestinal disorders?
This review highlights the potential of transcutaneous auricular vagus nerve stimulation as a novel neuromodulation therapy for functional gastrointestinal disorders.
Answers are grounded in this paper and cite their sources.
May support neuromodulation for functional gastrointestinal disorders; leaves open confirmation of efficacy and safety in randomized trials.
Functional gastrointestinal disorders (FGIDs) are debilitating diseases of the digestive system that severely impair an individual’s quality of life and impose a significant economic burden. However, the mechanisms underlying the pathogenesis of FGIDs and effective treatment options remain unclear. Transcutaneous auricular vagus nerve stimulation (taVNS), a novel neuromodulation therapy, has shown promising therapeutic outcomes in the treatment of FGIDs. This study conducted a comprehensive analysis of the development of taVNS and its relationship with vagus nerve stimulation and explored the clinical application of taVNS in managing FGIDs, including functional dyspepsia, irritable bowel syndrome, and functional constipation. Additionally, this study investigated the pathophysiological mechanisms of taVNS in FGIDs and reviewed its application as a holistic treatment approach, aiming to provide new insights into its therapeutic potential.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: